See more : Goodman Group (GMGSF) Income Statement Analysis – Financial Results
Complete financial analysis of China Pioneer Pharma Holdings Limited (1345.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Pioneer Pharma Holdings Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- AgriFORCE Growing Systems Ltd. (AGRIW) Income Statement Analysis – Financial Results
- Hong Seng Consolidated Berhad (0041.KL) Income Statement Analysis – Financial Results
- Power Finance Corporation Limited (PFC.NS) Income Statement Analysis – Financial Results
- Endurance RP Limited (RPGLF) Income Statement Analysis – Financial Results
- Ngern Tid Lor Public Company Limited (TIDLOR.BK) Income Statement Analysis – Financial Results
China Pioneer Pharma Holdings Limited (1345.HK)
About China Pioneer Pharma Holdings Limited
China Pioneer Pharma Holdings Limited, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. It has a portfolio of pharmaceutical products, such as ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas, as well as medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company sells its products to hospitals and medical institutions, and pharmacies. It also sells ancillary tools and leases accessories; and sells dental devices. In addition, the company engages in the sale of imported in-licensed prescription products. China Pioneer Pharma Holdings Limited was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. China Pioneer Pharma Holdings Limited is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.57B | 1.56B | 1.43B | 1.33B | 1.32B | 1.62B | 2.15B | 1.79B | 1.46B | 1.54B | 1.27B | 958.72M | 717.83M | 570.65M |
| Cost of Revenue | 898.43M | 775.57M | 662.79M | 724.07M | 636.18M | 991.88M | 1.43B | 1.20B | 998.32M | 1.05B | 885.60M | 651.98M | 522.13M | 404.56M |
| Gross Profit | 668.24M | 780.47M | 772.03M | 607.97M | 679.80M | 632.42M | 721.42M | 593.42M | 462.58M | 491.95M | 386.65M | 306.75M | 195.70M | 166.09M |
| Gross Profit Ratio | 42.65% | 50.16% | 53.81% | 45.64% | 51.66% | 38.94% | 33.49% | 33.15% | 31.66% | 31.94% | 30.39% | 32.00% | 27.26% | 29.11% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 112.11M | 82.08M | 72.33M | 65.46M | 84.18M | 74.35M | 66.56M | 73.37M | 66.75M | 55.04M | 33.57M | 28.67M | 18.33M | 15.57M |
| Selling & Marketing | 422.60M | 467.74M | 517.20M | 443.74M | 446.80M | 399.66M | 370.27M | 277.49M | 135.38M | 152.65M | 101.76M | 92.09M | 68.65M | 63.81M |
| SG&A | 534.71M | 548.28M | 584.79M | 534.84M | 541.32M | 482.77M | 436.83M | 350.86M | 202.12M | 207.70M | 135.33M | 120.76M | 86.99M | 79.38M |
| Other Expenses | 133.53M | 4.83M | 2.75M | 2.92M | 8.54M | 8.75M | 5.28M | 3.95M | 5.25M | 4.77M | 1.34M | 793.00K | 594.00K | 334.00K |
| Operating Expenses | 668.24M | 496.55M | 574.59M | 518.97M | 543.34M | 541.61M | 428.38M | 323.97M | 276.79M | 210.26M | 113.46M | 109.37M | 79.09M | 71.08M |
| Cost & Expenses | 1.39B | 1.27B | 1.24B | 1.24B | 1.18B | 1.53B | 1.86B | 1.52B | 1.28B | 1.26B | 999.06M | 761.35M | 601.22M | 475.64M |
| Interest Income | 585.00K | 10.58M | 4.01M | 6.35M | 12.01M | 16.30M | 16.28M | 12.90M | 21.01M | 23.00M | 702.00K | 14.43M | 7.46M | 5.83M |
| Interest Expense | 2.48M | 1.71M | 932.00K | 1.09M | 3.99M | 1.37M | 2.30M | 5.52M | 19.95M | 14.14M | 12.68M | 9.44M | 5.49M | 4.98M |
| Depreciation & Amortization | 18.95M | 13.63M | 12.95M | 8.35M | 8.86M | 8.09M | 8.32M | 13.18M | 16.88M | 7.60M | 2.48M | 2.82M | 2.53M | 1.98M |
| EBITDA | 201.88M | 245.38M | 199.96M | 104.79M | 161.31M | 157.74M | 292.91M | 255.74M | 243.63M | 291.86M | 287.65M | 219.09M | 131.11M | 103.84M |
| EBITDA Ratio | 12.89% | 15.77% | 13.94% | 6.10% | 11.18% | 9.71% | 13.60% | 14.28% | 18.98% | 18.95% | 19.95% | 22.68% | 17.79% | 18.25% |
| Operating Income | 180.21M | 232.19M | 187.24M | 73.13M | 138.47M | 149.66M | 284.59M | 242.56M | 260.45M | 284.25M | 251.32M | 214.64M | 125.14M | 102.13M |
| Operating Income Ratio | 11.50% | 14.92% | 13.05% | 5.49% | 10.52% | 9.21% | 13.21% | 13.55% | 17.83% | 18.45% | 19.75% | 22.39% | 17.43% | 17.90% |
| Total Other Income/Expenses | 239.00K | 55.45M | 12.76M | 22.22M | 10.00M | -42.54M | 3.92M | 11.41M | -53.66M | 13.73M | 21.16M | -7.80M | 6.48M | -5.25M |
| Income Before Tax | 180.45M | 294.50M | 201.45M | 95.34M | 148.47M | 107.11M | 309.32M | 282.35M | 206.80M | 304.69M | 272.49M | 206.84M | 123.09M | 96.88M |
| Income Before Tax Ratio | 11.52% | 18.93% | 14.04% | 7.16% | 11.28% | 6.59% | 14.36% | 15.77% | 14.16% | 19.78% | 21.42% | 21.57% | 17.15% | 16.98% |
| Income Tax Expense | 51.45M | 64.55M | 60.63M | 43.85M | 44.65M | 22.34M | 28.71M | 43.73M | 34.29M | 43.74M | 36.73M | 21.12M | 26.08M | 21.81M |
| Net Income | 145.72M | 235.30M | 142.63M | 52.45M | 104.63M | 84.60M | 278.93M | 237.45M | 174.30M | 261.72M | 238.37M | 186.37M | 95.68M | 70.44M |
| Net Income Ratio | 9.30% | 15.12% | 9.94% | 3.94% | 7.95% | 5.21% | 12.95% | 13.26% | 11.93% | 16.99% | 18.74% | 19.44% | 13.33% | 12.34% |
| EPS | 0.12 | 0.20 | 0.12 | 0.04 | 0.09 | 0.07 | 0.22 | 0.18 | 0.13 | 0.20 | 0.23 | 0.19 | 0.10 | 0.07 |
| EPS Diluted | 0.12 | 0.20 | 0.12 | 0.04 | 0.09 | 0.07 | 0.22 | 0.18 | 0.13 | 0.20 | 0.23 | 0.19 | 0.10 | 0.07 |
| Weighted Avg Shares Out | 1.18B | 1.19B | 1.20B | 1.21B | 1.22B | 1.25B | 1.29B | 1.30B | 1.31B | 1.33B | 1.05B | 983.38M | 983.38M | 983.38M |
| Weighted Avg Shares Out (Dil) | 1.18B | 1.19B | 1.20B | 1.21B | 1.22B | 1.25B | 1.29B | 1.30B | 1.31B | 1.33B | 1.05B | 983.38M | 983.38M | 983.38M |
Source: https://incomestatements.info
Category: Stock Reports